Please login to the form below

Not currently logged in
Email:
Password:

anti-CD3 mAb

This page shows the latest anti-CD3 mAb news and features for those working in and with pharma, biotech and healthcare.

Tiziana joins type 1 diabetes prevention field

Tiziana joins type 1 diabetes prevention field

Teplizumab is a mouse derived anti-CD3 mAb, and is administered intravenously. ... Now Tiziana is looking to rival Provention with the development of its own anti-CD3 mAB foralumab, which it says is the only entirely human anti-CD3 mAb.

Latest news

  • The impact of insulin

    Monoclonal antibodies. Tolerx and GSK are developing otelixizumab, an intravenous anti-CD3 humanised version of the monoclonal antibody (mAb) YTH-12.5. ... The US Juvenile Diabetes Research Foundation (JDRF) has provided $2m funding for a pivotal,

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....
Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams....